Lipoxin A4 attenuates the lung ischaemia reperfusion injury in rats after lung transplantation
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 53 (1) , 1143-1152
Abstract
Lung ischaemia reperfusion injury (LIRI) is the major cause of primary lung dysfunction after lung transplantation. Lipoxin A4 inhibits the oxidative stress and inflammation. This study aimed to ev...Keywords
Funding Information
- China Postdoctoral Science Foundation (2017T100251, LBH-Q9126)
This publication has 34 references indexed in Scilit:
- Lipoxin A4 reduces hyperoxia-induced lung injury in neonatal rats through PINK1 signaling pathwayInternational Immunopharmacology, 2019
- Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part III: Mechanisms: A 2016 Consensus Group Statement of the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2017
- Update on ischemia-reperfusion injury in lung transplantationCurrent Opinion in Organ Transplantation, 2015
- Lipoxin A4 suppresses the development of endometriosis in an ALX receptor‐dependent manner via the p38 MAPK pathwayBritish Journal of Pharmacology, 2014
- The role of pro‐resolution lipid mediators in infectious diseaseImmunology, 2014
- Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactionsProceedings of the National Academy of Sciences, 2012
- Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological processAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Outcome of lung transplanted patients with primary graft dysfunctionEuropean Journal of Cardio-Thoracic Surgery, 2007
- Risk factors for reperfusion injury after lung transplantationIntensive Care Medicine, 2006
- Ischemia–Reperfusion–induced Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2003